Servier and generics firms to appeal EU verdict on perindopril 'sweetheart' deals
This article was originally published in SRA
Executive Summary
The European Commission has imposed fines totaling Euros 427.7 million on Servier and five producers of generic medicines for anti-competitive practices – a decision that the French drug maker says sets a "regrettable precedent" for industries that rely on intellectual property1,2.